SEC Form 4 · accession 0001209191-17-038100
GLOBUS MEDICAL INC · GMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony L Williams
Officer — President
Period of report
Jun 5, 2017
Accepted (ET)
Jun 6, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001237831
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 5, 2017 | M | 16,153 | $11.28 | A | 16,153 | D | |
| Class A Common StockF2 | Jun 5, 2017 | S | 16,153 | $31.941 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F3 | $11.28 | Jun 5, 2017 | M | 16,153 | D | — | Apr 20, 2021 | Class A Common Stock | 16,153 | 0 | D |
Explanation of responses
- F1This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on May 5, 2017, which is intended to comply with Rule 10b5-1.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.78 to $32.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3These options were granted on April 20, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on March 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.